Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2.
about
Roscovitine in cancer and other diseasesProteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancersInhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer.Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells.Multispectral imaging and pathology: seeing and doing more.PPARβ Regulates Liver Regeneration by Modulating Akt and E2f Signaling.The prognostic value of phosphorylated Akt in breast cancer: a systematic review.A splice variant of HER2 corresponding to Herstatin is expressed in the noncancerous breast and in breast carcinomas.Increased Level of Phosphorylated ShcA Measured by Chemiluminescence-Linked Immunoassay Is a Predictor of Good Prognosis in Primary Breast Cancer Expressing Low Levels of Estrogen Receptor.The CDK inhibitors in cancer research and therapy.The Aurora kinase inhibitors in cancer research and therapy.Multi-kinase inhibitors, AURKs and cancer.Down-regulation of Akt by methanol extracts of Impatiens balsamina L. promotes apoptosis in human oral squamous cell carcinoma cell lines.Metabolomics in pancreatic cancer biomarkers research.Biological Activities of Essential Oils: From Plant Chemoecology to Traditional Healing Systems.KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma.B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells.Chemistry and biology of essential oils of genus boswellia.Lack of AKT activation in lung cancer cells with EGFR mutation is a novel marker of cetuximab sensitivity.Effects of cold ischemia and inflammatory tumor microenvironment on detection of PI3K/AKT and MAPK pathway activation patterns in clinical cancer samples.Sulforaphane-Induced Cell Cycle Arrest and Senescence are accompanied by DNA Hypomethylation and Changes in microRNA Profile in Breast Cancer Cells.CTEN (C-terminal tensin-like), a novel oncogene overexpressed in invasive breast carcinoma of poor prognosis.JNK, p38, ERK, and SGK1 Inhibitors in Cancer.PIK3CA mutations and their response to neoadjuvant treatment in early breast cancer: A systematic review and meta-analysis.PKIB expression strongly correlated with phosphorylated Akt expression in breast cancers and also with triple-negative breast cancer subtype.Kinases and cancer
P2860
Q26799874-D680B66A-5043-4FAA-9A5A-2E51BF0B6EFFQ30388028-98C90FED-3BD9-46DB-9C92-918728030FD2Q34043823-E1B4F2E6-7CD5-456A-8654-8ACF72AF7EE7Q34101905-A0591AC7-679F-4D1B-8792-AF28F940CC67Q34621288-225D01C1-4A6F-47B0-860A-03F66DD4549DQ34792575-E7BCD7CE-06B1-4797-917E-037E031E2D88Q34925401-595F31BE-5BE2-44EE-AA32-5D5814DC614EQ36730394-003083DF-D86C-48C7-8BDC-B68B0D5912A2Q37307192-BCECFCB9-E8C1-472D-B5F2-1197A4074EBCQ37923861-8A47D789-04F0-4EDC-BAE0-88AC92B7832BQ38756932-81FD26D0-905B-4ECD-AD40-6FB3FB92612DQ38796360-301584B7-12C5-4161-B624-565A3AF91378Q38957423-F931C770-2F50-4237-8230-D7F524AFC0FAQ38997162-44108435-8FCA-4A01-BBAD-2EE47B122E2DQ39065656-8323A191-F6FB-4946-B700-956369EEEA6EQ39078976-CD16410A-2D46-443E-B4D1-0950D123274FQ39154102-62E13B2E-4A6B-4EC2-9674-99288BC99724Q39243722-9DEF9AFF-380D-4084-9517-7A0BC0D5ADE4Q39400167-92746813-F7DF-414F-9D5F-CA5833AF7FD8Q39418566-50466031-833E-4EF2-BCD3-64AF8B814AE5Q41174242-7F06A1C6-F0D6-4FC4-B375-14BD1E2CF269Q43722435-67A19DBF-8229-4D4F-B774-9B20E1F9739BQ47265464-38FCD220-64A0-4508-AEC2-378271FCE89EQ52633197-7036CE47-D8F0-45D0-8896-B628375D6E86Q54466754-B0119582-99DD-486F-A0C0-C8A5146BFFF5Q54670763-AD1C9235-13DE-4ED0-844D-3D8B911117F1
P2860
Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Increased level of phosphoryla ...... t cancer overexpressing ErbB-2
@nl
Increased level of phosphoryla ...... cancer overexpressing ErbB-2.
@ast
Increased level of phosphoryla ...... cancer overexpressing ErbB-2.
@en
type
label
Increased level of phosphoryla ...... t cancer overexpressing ErbB-2
@nl
Increased level of phosphoryla ...... cancer overexpressing ErbB-2.
@ast
Increased level of phosphoryla ...... cancer overexpressing ErbB-2.
@en
prefLabel
Increased level of phosphoryla ...... t cancer overexpressing ErbB-2
@nl
Increased level of phosphoryla ...... cancer overexpressing ErbB-2.
@ast
Increased level of phosphoryla ...... cancer overexpressing ErbB-2.
@en
P2093
P2860
P356
P1476
Increased level of phosphoryla ...... t cancer overexpressing ErbB-2
@en
P2093
Edward Wight
Mark Mayhew
Martin Labuhn
Patrick Urban
Serenella Eppenberger-Castori
Urs Eppenberger
Vincent Vuaroqueaux
Willy Küng
P2860
P2888
P304
P356
10.1186/BCR1015
P407
P577
2005-03-24T00:00:00Z
P5875
P6179
1043159265